Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | VDR | P11473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.41 |
| ▸ | CLTC | Q00610 | 8/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19791320 | 0.89 | TDP1 (0.47) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL23592285 | 0.88 | TDP1 (0.46) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL19985743 | 0.88 | KDM4E (0.47) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL19985727 | 0.87 | TDP1 (0.46) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL19985733 | 0.87 | TDP1 (0.46) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL19985725 | 0.87 | TDP1 (0.46) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL23592280 | 0.87 | TDP1 (0.46) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL23592282 | 0.87 | TDP1 (0.46) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL19791413 | 0.87 | KDM4E (0.45) | KDM4EALDH1A1HPGDMAPTKMT2A | |
| SCHEMBL215202 | 0.84 | ALDH1A1 (0.64) | KDM4EALDH1A1HPGDMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079724-A1 | SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
| US-20180079724-A1 | SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079724-A1 | SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION | ALAD, ADSL, ACSL3 | KDM4E 3505/4885ALDH1A1 352/4885HPGD 2726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.